Insomnia
Not yet recruitingStudy on the Effectiveness and Safety of AV-EC2023 Tablets for Adults with Insomnia
Germany- Participants:18–64 years
- Substances:Av-Ec2023
- Sponsor:A.Vogel AG
Rare diseases
Investigational molecules
Locations

Grunaustrasse 4, 9325
The sponsor demonstrates a commitment to advancing evidence-based phytotherapy through systematic clinical investigation. Their research portfolio centers on developing and validating herbal medicinal products derived from botanical sources, with particular emphasis on establishing clinical efficacy and safety profiles through rigorous scientific methodology. The organization focuses on translating traditional plant-based therapeutic approaches into modern pharmaceutical applications, bridging complementary medicine with conventional clinical standards.
This research direction reflects a specialized interest in natural product pharmacology and the scientific substantiation of traditional herbal remedies, contributing to the growing body of evidence supporting integrative medical approaches in contemporary healthcare settings.
A.Vogel AG runs clinical trials in conditions such as Insomnia, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.